Corcept is leading the way in the research and development of cortisol modulators, molecules that regulate cortisol activity at the glucocorticoid receptor (GR). To date, we have discovered more than 1,000 selective proprietary cortisol modulators. In 2012, we received FDA approval of Korlym® (mifepristone), the first approved treatment for hypercortisolism (Cushing’s syndrome). Today, our team and collaborators continue to unlock the possibilities of cortisol modulation as a way to treat serious diseases. With more than 30 ongoing studies across a wide range of disease areas, including endocrinology, oncology, metabolism, and neurology, we remain dedicated to advancing the possibilities of cortisol modulation. What began as a ripple of scientific truth is now poised to unleash a sea change of discovery representing a fundamental shift in the way we understand and treat disease. Come spend your summer working with passionate colleagues and inspirational leaders, all while gaining world-class experience in one of the fast-growing biotechs in the Bay Area. The Medical Affairs Intern will support the Medical Strategy team in executing key initiatives that bridge scientific knowledge with strategic business objectives. This role offers exposure to cross-functional collaboration, medical content development and insights generation to support product lifecycle management.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Intern
Education Level
No Education Listed
Number of Employees
251-500 employees